roypounder.apt (@apandt) 's Twitter Profile
roypounder.apt

@apandt

@APandT new papers in AP&T, summaries free-to-view. 2023 Impact Factor is 6.6, ranking AP&T 18/97 for journals in Gastroenterology & Hepatology.

ID: 932532385

linkhttp://www.apandt.org calendar_today07-11-2012 17:23:03

3,3K Tweet

2,2K Takipçi

566 Takip Edilen

roypounder.apt (@apandt) 's Twitter Profile Photo
roypounder.apt
@apandt

2 months ago

"Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal Cohort" now available to read 'open access' via bit.ly/4i5Wz62 #livertwitter #HCC #atezolizumab #bevacizumab

"Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal Cohort" now available to read 'open access' via bit.ly/4i5Wz62 #livertwitter #HCC #atezolizumab #bevacizumab